- Home
- » Tags
- » Vaccination
Top View
- Vaccine R&D Success Rates and Development Times
- FAQ191 -- Human Papillomavirus (HPV) Vaccination
- Rapid Review: Post-Vaccination Transmission
- The Difficult Road to Compelling Vaccination for Sexually
- Vaccination and Herd Immunity to Infectious Diseases Roy M
- Guidance for Close Contacts of a Person Confirmed to Have COVID-19
- Global Immunization and Gavi Five Priorities for the Next Five Years Center for Global Development
- Pandemrix, INN-Influenza Vaccine (H1N1)V (Split Virion, Inactivated, Adjuvanted)
- 2021 Recommended Child and Adolescent Immunization Schedule
- Evidence Brief: Risk of COVID-19 Transmission from Vaccinated Cases Page 1 of 9
- Covid-19 Vaccine: Frequently Asked Questions
- Guidelines for Epidemic Preparedness and Response to Measles Outbreaks
- Neutralizing Activity of BBIBP-Corv Vaccine-Elicited Sera Against Multiple SARS-Cov-2 Variants of Concern
- Michigan COVID-19 Vaccination Interim Prioritization Guidance
- Understanding Thimerosal, Mercury, and Vaccine Safety
- An Appraisal of the Current Scenario in Vaccine Research for COVID-19
- Global Vaccination: Trends and U.S
- Pandemrix Vaccine: Why Was the Public Not Told of Early Warning Signs?
- Six Month Safety and Efficacy of the Bnt162b2 Mrna COVID-19 Vaccine
- Epidemiological Differences in the Impact of COVID-19 Vaccination in the United States and China
- COVID-19 Vaccines: a Review of the Safety and Efficacy of Current
- STUDY PROTOCOL V122 01 Version 1.0
- Airfinity COVID-19 Vaccine Production
- Design of Vaccine Efficacy Trials to Be Used During Public Health Emergencies – Points of Considerations and Key Principles
- Self-Assessment of COVID-19 Vaccination Efficacy Using a Lateral Flow Tests for SARS-Cov-2 S1 Protein Antibody
- Lost Your Vaccine Card? You Should Get a Card When You Get Your COVID-19 Vaccination That Includes the Name of the Vaccine Product and the Date You Got It
- Narcolepsy and Influenza A(H1N1) Pandemic 2009 Vaccination in the United States
- Hb 702 Enrolled Bill an Act Prohibiting Discrimination
- Vaccinations Are Safe: Explaining
- UNICEF's Engagement with Gavi, the Vaccine Alliance
- Myopericarditis Following COVID-19 Vaccination: Updates from the Vaccine Adverse Event Reporting System (VAERS) Aug 30, 2021
- Evidence Assessment: Sinopharm/BBIBP COVID-19 Vaccine
- Vaccine Safety
- Vaccination (Immunization) – Medicare Advantage Policy Guideline
- Pfizer-Biontech Covid-19 Vaccine to Prevent Coronavirus Disease 2019 (Covid-19)
- Vaccination Matters Order
- Digital Documentation of COVID-19 Certificates: Vaccination Status
- Adult Immunization Schedule
- Section 4 Diseases Preventable by Routine Vaccination
- Screening Checklist for Contraindications to Vaccines For
- A Study of the Side Effects of Pandemrix® Influenza (H1N1) Vaccine After Whole-Crew Vaccination on Board a Norwegian Naval Vessel
- Roadmap to Implementing Pandemic Influenza Vaccination of Critical Workforce
- Background Information on Vaccine Safety and Efficacy Policy POC: Christopher Bennett, (202) 621-1684
- Memorandum for Mandatory Coronavirus Disease
- Use of Gavi Support to Maintain, Restore and Strengthen Immunisation in the Context of COVID-19
- COVID-19 Vaccination Reporting Updated As of 8A.M
- Narcolepsy Associated with Pandemrix Vaccine
- PR Vaccination GAVI
- Prevaccination Checklist for COVID-19 Vaccines
- Pfizer-Biontech COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers
- Addressing Vaccine Hesitancy: Latest Evidence & Future Directions
- COVID-19 Vaccine Clinical Guidance Summary for Patients with Rheumatic and Musculoskeletal Diseases
- Mass Vaccination and COVID-19
- SEXUALLY TRANSMITTED INFECTIONS (Stis)
- From the Front Lines: COVID-19 Vaccination Efforts in Rural Communities Hit by the Opioid Epidemic JBS International RCORP-Evaluation Team
- Vaccine-Preventable Diseases and Vaccines
- Human Papillomavirus Vaccination Among Adults Aged 18−26, 2013−2018Pdf Icon
- Asymptomatic Covid-19 Carriers Education App
- Emergency Use Authorization for Vaccines to Prevent COVID-19
- Neutralization of SARS-Cov-2 VOC 501Y.V2 by Human Antisera Elicited by Both
- COVID-19 Vaccination Communication Executive Summary
- Vaccine Safety Basics Learning Manual
- Alabama COVID-19 Vaccination Allocation Plan
- Oppose HB-6423 and SB-568
- Vaccine Safety Issues at the Turn of the 21St Century
- Pandemrix, INN-Pandemic Influenza Vaccine (H1N1) (Split Virion
- Vaccines National Strategic Plan 2021-2025
- On the Implications of Desexualizing Vaccines Against Sexually Transmitted Diseases: Reflections from a Practicing Pediatrician Amanda F
- COVID-19 Vaccine Hesitancy: Demographic Factors, Geographic Patterns, and Changes Over Time
- ASHP Guidelines on the Pharmacist's Role in Immunization
- SARS-Cov-2 Vaccine Testing and Trials in the Pediatric Population: Biologic, Ethical, Research, and Implementation Challenges
- GAVI Profile
- Immunisation, Asymptomatic Infection, Herd Immunity and the New Variants of COVID 19
- 2021.07.15.21260362V1.Full.Pdf
- Influenza and Influenza Vaccine Myths and Reality
- Immunization: Vital Progress, Unfinished Agenda
- Gavi, the Vaccine Alliance. 2016-2020 Strategy
- Clear Answers and Smart Advice About Your Baby's Shots
- A Review of Thimerosal in Vaccines
- Factors Associated with COVID-19 Vaccine Hesitancy
- Narcolepsy, Autoimmunity, and Influenza a H1N1 Vaccination